Quantitative Insights Information

Quantitative Insights (QI) provides the industry’s first artificial intelligence based computer-aided diagnosis system, QuantX™. This FDA-cleared device has been shown to improve the accuracy of cancer diagnosis. Based on technology licensed from the University of Chicago, QuantX™ improves radiologist performance while significantly reducing costs, thereby enabling faster and more accurate diagnosis, more personalized treatments, and better outcomes for patients. QI has successfully commercialized QuantX™ as a platform system supporting a broad range of software solutions for breast cancer decision support. The QuantX-exclusive QI Score™ and Similar Case Database Compare™ provide similarity assessment to a robust database of lesions with known pathology based on biopsy results. QuantX has been shown to reduce missed cancers by 39% and improve reading time for these complex multi-modality cases by more than 50%. QuantX™ utilizes advanced quantitative image analytics and machine learning technologies now at the forefront of innovation in radiology. The company touts an impressive roadmap of clinical solutions based on these next generation technologies, including deep learning applications.